Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7745216 Methods and reagents for treating glucose metabolic disorders

Patent 7745216 was granted and assigned to Curis Limited on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kevin Pang0

Kuanghui Lu0

Date of Patent

June 29, 2010

0

Patent Application Number

108556760

Date Filed

May 27, 2004

0

Patent Citations Received

US Patent 11911445 Peptide YY pharmaceutical formulations, compositions, and methods

0

US Patent 11987813 Microenvironments for self-assembly of islet organoids from stem cells differentiation

0

US Patent 11957895 Glucose-based modulation of electrical stimulation to enable weight loss

0

US Patent 11712562 Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy

0

Patent Primary Examiner

Marianne P Allen

0

Patent abstract

The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7745216 Methods and reagents for treating glucose metabolic disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.